Table 1.
Association of ATF4 expression with clinical and pathological characteristics of 199 ccRCC patients in TMAs
| Characteristic | ATF4 expression | P-value | |
|---|---|---|---|
| High(n = 62) | Low(n = 137) | ||
| Age | 53.60 ± 9.99 | 53.68 ± 9.41 | 0.955 |
| BMI | 25.66 ± 3.41 | 25.68 ± 3.16 | 0.961 |
| Sex | 0.069 | ||
| Male | 53 (85.48%) | 100 (72.99%) | |
| Female | 9 (14.52%) | 37 (27.01%) | |
| T stage | 0.0012* | ||
| T1 + T2 | 37 (59.68%) | 113 (82.48%) | |
| T3 + T4 | 25 (40.32%) | 24 (17.52%) | |
| N stage | 0.3319 | ||
| N0 | 59 (92.19%) | 131(95.62%) | |
| N1 | 5 (7.81%) | 6 (4.38%) | |
| M stage | 0.0122* | ||
| M0 | 56 (90.32%) | 135 (98.54%) | |
| M1 | 6 (9.68%) | 2 (1.46%) | |
| Fuhrman | 0.0010* | ||
| Grade I–II | 41 (66.13%) | 119 (86.86%) | |
| Grade III + IV | 21 (33.87%) | 18 (13.14%) | |
*P < 0.05 indicates a significant association among the variables